1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Guardion Health Sciences, Inc.

Guardion Health Sciences, Inc.

GHSI
Guardion Health Sciences, Inc.US flagOther OTC
3.25
USD
+0.03
- -
4.17MMarket Cap

Income Statement (USD)

APIChatGPT
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Sales/Revenue/Turnover
- -
- -
- -
1
1
2
7
11
12
+ Sales & Services Revenue
- -
- -
- -
1
1
2
7
11
12
- Cost of Revenue
- -
- -
- -
- -
- -
2
4
7
7
+ Cost of Goods & Services
- -
- -
- -
- -
- -
2
4
7
7
Gross Profit
- -
- -
- -
1
1
- -
3
5
5
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
6
4
6
7
9
8
14
12
9
+ Selling, General & Admin
6
4
5
6
9
8
14
12
9
+ Research & Development
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-6
-4
-5
-6
-9
-9
-10
-7
-4
- Non-Operating (Income) Loss
3
2
- -
2
2
- -
14
8
-4
+ Interest Expense, Net
1
1
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
1
1
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
2
1
- -
2
2
- -
14
8
-4
Pretax Income
-9
-6
-5
-8
-11
-9
-25
-15
- -
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-9
-6
-5
-8
-11
-9
-25
-15
- -
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-9
-6
-5
-8
-11
-9
-25
-15
- -
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-9
-6
-5
-8
-11
-9
-25
-15
- -
- Preferred Dividends
- -
1
1
- -
- -
- -
- -
1
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-9
-7
-6
-8
-11
-9
-25
-16
- -
EBIT
-6
-4
-5
-6
-9
-9
-10
-7
-4
EBITDA
-6
-4
-5
-6
-8
-8
-10
-6
-4
EBITDA Margin (%)
-5,386.35
-2,578.07
-1,180.44
-620.71
-920.07
-438.27
-134.11
-54.95
-32.02
EBITA
-6
-4
-5
-6
-9
-9
-10
-7
-4
Gross Margin (%)
55.61
46.32
59.88
57.74
62.2
-3.01
43
40.91
44.04
Operating Margin (%)
-5,433.99
-2,620.7
-1,207.6
-652.09
-989.37
-449.89
-144.94
-66.26
-32.18
Profit Margin (%)
-7,837.26
-4,076.04
-1,213.03
-824.43
-1,204.77
-453.56
-342.11
-135.05
1.29
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
1
- -
1
1
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
1
1
Basic EPS, GAAP
-120.98
-89.54
-85.06
-105.09
-89.49
-30.06
-52.23
-14.15
0.12
Basic EPS from Cont Ops
-120.98
-78.66
-72.6
-105.09
-89.49
-30.06
-52.23
-13.31
0.12
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
1
1
Diluted EPS, GAAP
-120.98
-89.54
-85.06
-105.09
-89.49
-30.06
-52.23
-14.15
0.12
Diluted EPS from Cont Ops
-120.98
-78.66
-72.6
-105.09
-89.49
-30.06
-52.23
-13.31
0.12

Balance Sheet (USD)

APIChatGPT
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
Total Current Assets
- -
- -
5
1
12
9
12
22
12
+ Cash, Cash Equivalents & STI
- -
- -
5
1
11
9
9
11
6
+ Cash & Cash Equivalents
- -
- -
5
1
11
9
4
11
6
+ ST Investments
- -
- -
- -
- -
- -
- -
5
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
1
2
2
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
1
2
2
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
3
3
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
3
3
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
- -
- -
- -
1
6
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
2
3
1
1
11
- -
- -
+ Property, Plant & Equip, Net
- -
- -
- -
- -
1
1
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
1
1
1
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
2
2
- -
- -
11
- -
- -
+ Total Intangible Assets
- -
- -
2
2
- -
- -
11
- -
- -
+ Goodwill
- -
- -
2
2
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
1
- -
- -
- -
11
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
- -
- -
7
4
13
10
23
22
12
+ Payables & Accruals
1
1
- -
- -
- -
1
1
2
1
+ Accounts Payable
- -
- -
- -
- -
- -
1
- -
2
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
- -
- -
- -
- -
1
1
1
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
- -
- -
- -
2
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
2
- -
Total Current Liabilities
1
1
- -
- -
- -
1
1
4
1
+ LT Debt
1
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
1
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
5
2
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
5
2
Total Noncurrent Liabilities
1
- -
- -
- -
- -
- -
- -
5
2
Total Liabilities
1
1
- -
- -
1
1
1
9
4
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
5
- -
+ Share Capital & APIC
13
20
34
38
58
63
101
102
102
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
13
20
34
38
58
63
101
102
102
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-14
-21
-27
-35
-46
-54
-79
-94
-94
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-1
- -
7
3
12
9
22
13
8
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-1
- -
7
3
12
9
22
13
8
Total Liabilities & Equity
- -
- -
7
4
13
10
23
22
12
Shares Outstanding
- -
- -
- -
- -
- -
- -
- -
1
1
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
1
- -
- -
- -
- -
Net Debt
1
- -
-5
-1
-11
-9
-4
-11
-6
Net Debt to Equity
-61.72
-2.56
-68.48
-21.06
-92.38
-100.04
-18.36
-80.92
-78.07
Tangible Common Equity Ratio
-499.48
-132.53
90.36
70.19
93.41
86.28
90.47
36.51
68.35
Current Ratio
0.07
0.23
10.16
2.23
28.93
8.47
10.41
5.39
9.01
Cash Conversion Cycle
- -
-1,103.05
-188.01
34.52
42.41
7.29
31.45
117.97
156.21

Cash Flow Statement (USD)

APIChatGPT
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
As of date
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
+ Net Income
-9
-6
-5
-8
-11
-9
-25
-15
- -
+ Depreciation & Amortization
- -
- -
- -
- -
1
- -
1
1
- -
+ Non-Cash Items
8
4
2
3
5
1
14
8
-4
+ Stock-Based Compensation
5
2
2
2
3
-1
- -
- -
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
2
1
12
10
- -
+ Other Non-Cash Adj
3
2
- -
2
- -
1
2
-2
-4
+ Chg in Non-Cash Work Cap
- -
- -
- -
- -
- -
- -
- -
-2
-1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
-1
- -
-3
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
-1
- -
- -
+ Inc (Dec) in Accts Payable
- -
- -
- -
- -
- -
1
- -
1
-1
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-1
-2
-3
-4
-6
-8
-11
-7
-4
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
5
1
16
- -
34
9
- -
+ Increase in Capital Stock
- -
- -
5
1
16
- -
34
9
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
-5
5
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
66
83
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
-71
-78
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
-26
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
-26
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
-31
5
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
1
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
1
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
1
3
- -
- -
5
4
5
-5
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
1
2
8
- -
17
5
37
14
-5
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
5
-4
10
-3
-4
12
-10
EBITDA
-6
-4
-5
-6
-8
-8
-10
-6
-4
EBITDA Margin (%)
-5,386.35
-2,578.07
-1,180.44
-620.71
-920.07
-438.27
-134.11
-54.95
-32.02
Free Cash Flow
-1
-2
-3
-4
-6
-8
-11
-7
-4
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
26
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
-4
Free Cash Flow to Equity
- -
-2
-4
-4
-6
-8
-11
-3
-10
Free Cash Flow per Basic Share
-15.63
-22.67
-47.09
-60.67
-51.01
-28.25
-22.62
-6.65
-3.44
Price/Free Cash Flow
- -
- -
- -
- -
-0.72
-2.34
-0.76
-0.57
-0.82
Cash Flow to Net Income
0.13
0.29
0.64
0.54
0.55
0.93
0.43
0.5
-27.65
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -
- -
- -